Artesunate Amivas
artesunate
Malaria
Date of authorisation:
Revision: 4
Last updated:
MedicineHumanAuthorised
EMEA-002535-PIP04-21 - paediatric investigation plan
Decision type: P: decision agreeing on a investigation plan, with or without partial waiver(s) and or deferral(s)
Therapeutic area: Infectious diseases
PIP number: P/0370/2022
Route(s) of administration: Oral useIntravenous use
Pharmaceutical form(s):
Tablet
Powder for oral solution
Powder for solution for injection or infusion
Decision date:
Last updated:
Compliance check: ✖
PIPHuman
EMEA-002710-PIP01-19 - paediatric investigation plan
Decision type: P: decision agreeing on a investigation plan, with or without partial waiver(s) and or deferral(s)
Therapeutic area: Infectious diseases
PIP number: P/0328/2020
Route(s) of administration: Intravenous use
Pharmaceutical form(s):
Powder for solution for injection
Decision date:
Last updated:
Compliance check: ✔
PIPHuman
Garsun
artesunate
Date of withdrawal:
Last updated:
MedicineHumanWithdrawn application
Pyramax
artesunate
pyronaridine
Malaria
Positive opinion
Opinion date:
Last updated:
EU-M4allHuman
EMEA-002402-PIP02-18 - paediatric investigation plan
Decision type: P: decision agreeing on a investigation plan, with or without partial waiver(s) and or deferral(s)
Therapeutic area: Infectious diseases
PIP number: P/0423/2019
Route(s) of administration: Intravenous use
Pharmaceutical form(s):
Powder for solution for injection
Decision date:
Last updated:
Compliance check: ✖
PIPHuman